Reviv3 Procare Q1 net sales up 44.1% to $6.1M, net income down 12%

Axil Brands, Inc.

2023-Q1 EPS reported $0.00 revenue$6,106,269

Net sales for quarter ended Aug 31, 2023: $6.1M vs $4.2M prior year (+44.1%).
Net income $154K vs $175.5K prior year; EPS $0.00 basic and diluted.
Gross margin 76.1% vs 77.5%; operating expenses 73.3% of sales vs 72.8%.
Cash balance $5.06M at quarter end, up from $4.83M; expanding global retail presence.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Axil Brands, Inc. reported financial results for the three months ended August 31, 2023.

Period: the three months ended August 31, 2023
Result: reported results

Exact text from the filing

On October 13, 2023, Reviv3 Procare Company (the “Company”) issued a press release announcing its consolidated financial results for the three months ended August 31, 2023.

View on SEC.gov

Browse all earnings releases →

Axil Brands, Inc. filing history →

Source: SEC EDGAR

accession 0001520138-23-000444

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.